Profile
Nextech Invest is a venture capital firm specializing in the life sciences sector, particularly in biotechnology and pharmaceuticals. The firm is based in Switzerland and the USA, drawing on a deep reservoir of global scientific and investment expertise to support innovative companies aimed at advancing healthcare solutions. The team is composed of experienced partners and scientific advisors known for their strategic insights and profound knowledge of the biotechnology domain. What sets Nextech apart is its fusion of scientific expertise and rigorous investment methods to significantly contribute to patient care and provide strong returns for their investors.
The firm focuses on sectors such as biotechnology, pharmaceuticals, and healthtech, investing predominantly in early to late-stage companies. While specific check sizes are not detailed on the site, their fund sizes and healthcare focus suggest significant participation in series A to late-stage rounds. Nextech Invest collaborates with strategic partners to facilitate robust growth and successful business strategies for its portfolio companies.
Notable investments include companies like Foundation Medicine, acquired by Roche for $5 billion, Blueprint Medicines, Relay Therapeutics, and Tango Therapeutics among others. These investments demonstrate Nextech's commitment to supporting groundbreaking health science innovations that have a lasting impact on patient care and the healthcare industry worldwide.
Industry
Nextech Invest Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Nextech Fund II
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
Life Sciences
|
Pre-seed
Seed
|
North America
Europe
|
$5-10 m
|
$100 M
|
October 2014
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.